The Ebola Epidemic Crystallizes the Potential of Passive Antibody Therapy for Infectious Diseases

Open Access

Pearls provide concise, practical and educational insights into topics that span the pathogens field.

Arturo Casadevall ,

* E-mail: acasade1@jhu.edu

Affiliation Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
⨯
Liise-anne Pirofski

Affiliations Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, New York, United States of America, Department of Medicine (Infectious Diseases), Albert Einstein College of Medicine, New York, New York, United States of America
⨯

Reader Comments (0)

Antibody therapy
Is the Subject Area "Antibody therapy" applicable to this article?

Thanks for your feedback.
Ebola virus
Is the Subject Area "Ebola virus" applicable to this article?

Thanks for your feedback.
Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.
Infectious diseases
Is the Subject Area "Infectious diseases" applicable to this article?

Thanks for your feedback.
Antimicrobials
Is the Subject Area "Antimicrobials" applicable to this article?

Thanks for your feedback.
Ebola hemorrhagic fever
Is the Subject Area "Ebola hemorrhagic fever" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Respiratory infections
Is the Subject Area "Respiratory infections" applicable to this article?

Thanks for your feedback.